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Abstract: Obesity is a disease characterized by excessive body fat. Among the 
neurobiological factors associated with obesity, the serotonergic system stands out. The 
neurotransmitter of these circuits is serotonin (5-HT). Decreased levels of 5-HT have been 
linked to increased desire to ingest sweets and carbohydrates. This study aims to verify the 
relationship of the 5HT2A T102C gene polymorphism with obesity and anthropometric 
parameters. Blood samples and anthropometric data were collected from 150 volunteers, 
divided between the control and obese groups. The results showed that for individuals 
with diastolic pressure (p = 0.3681), Estimated Mean Glycemia (GMe) (p = 0.0228) and 
Homeostatic Model Assessment (HOMA-IR-IR) (p = 0.001) all altered, a higher frequency 
of C alleles was observed. For normal GMe (p = 0.0270), a higher frequency of the T allele 
was observed. There was no difference for the allele distribution between the normal 
and altered groups for the parameters of Triglycerides, HDL cholesterol, total cholesterol, 
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glycated hemoglobin and Insulin. The distribution of the alleles between the groups, 
normal diastolic pressure (p = 0.3681) and HOMA-IR (p = 0.9203) groups presented no 
difference. From the genotypic analyzes of the T102C polymorphism of the 5HT2A gene, 
it was possible to demonstrate a relationship between the presence of the C allele with 
biochemical and anthropometric markers related to obesity and hypertension.
Keywords: Obesity. 5HT2A. Polymorphism. Cholesterol. BMI.
1 INTRODUCTION
Obesity is a disease characterized by excessive body fat that causes damage of 
varying degrees and undesirable consequences to the health of individuals. The disease 
has been emerging in recent years in countries with high or low economic development 
and presents a risk similar to underweight, malnutrition and infectious diseases to public 
health.1 Currently, obesity is among the main causes of other secondary diseases such as 
type 2 diabetes, cardiovascular disease, high cholesterol, infertility and even some types of 
cancer, creating a high cost of health care for the treatment of such diseases.2
The etiology of obesity is multifactorial and therefore complex, involving the 
interaction of environmental, behavioral, genetic, endocrine, metabolic and neural 
factors. Bechtholt, Smith, Gaughan and Lucki3 suggest that the study of neural genes with 
psychophysiological functions has gained attention in the field of obesity, because they 
are associated with appetite control and satiety, thus interconnecting them with being 
overweight.
Among the neurobiological factors associated with obesity, the serotonergic 
system stands out. Anatomical, pharmacological and genetic evidences suggest a strong 
correlation between these circuits and a series of psychosocial actions and regulation of 
physiological processes of the central nervous system, such as the control of energy levels, 
glucose homeostasis and satiety.4 The neurotransmitter of these circuits is serotonin (5-HT), 
chemically this molecule is characterized as an indolamine, a product of the hydroxylation and 
carboxylation of the amino acid tryptophan, produced in the nuclei of the brain stem raphe.5
Several studies suggest that 5-HT plays an important role in satiety. Changes in 5-HT 
levels (low levels or problems with receptor signaling) have been linked to an increased desire 
to eat sweets and carbohydrates. With normal amounts of 5-HT, the individual reaches 
satiety more easily and gets more control over the intake of sugars. Adequate levels of this 
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neurotransmitter in the brain depend on the dietary intake of tryptophan (precursor amino 
acid serotonin) and carbohydrates.6,7 Drugs that inhibit 5-HT reuptake are increasingly used 
for weight loss, being used in the treatment of obesity, since they intensify the satiety power 
in the components of post-ingestion and post-absorption of food.5,8
Considering the metabolic role of serotonin, researchers studied the genetic 
and molecular mechanisms of this system. According to Yuan, Yamada K, Ishiyama-
Shigemoto, Koyama and Nonaka,9 at least seven types of serotonin receptors (5HT-R) 
were characterized and at least two polymorphisms were recognized for types 1, 2 and 5.
In the region 102, is located the polymorphism T102C, in which a thymine (T) or 
a cytosine (C) can be positioned and thus expressing three possibilities of combinations 
for the 5-HT2A gene (genotypes TT, CT or CC). Both the TCT or TCC sequences in that 
region, encode the serine, not altering the amino acid sequences of the receptor. However, 
the T and C alleles determine a different gene expression, since Polesskaya and Sokolov10 
demonstrated that the expression of the C allele is 20% lower in comparison to the T 
allele, generating lower uptake of serotonin.
Further research to more accurately determine the role of the 5-HT 2A receptor 
in obesity in order to identify regulatory pathways and serotonin influences on appetite 
may be useful in the development of new drugs for the treatment of obesity disease.11 
In view of the above, this study aims to verify the relationship of the 5HT2A T102C gene 
polymorphism with obesity and anthropometric parameters.
2 MATERIAL AND METHODS
2.1 DELIMITATION OF THE STUDY
This was a descriptive, cross-sectional study aimed at obtaining a clinical, 
epidemiological, laboratory and molecular evaluation, in order to investigate the prevalence 
of 5HT2A gene polymorphism in samples of obese adults from the far west of Santa 
Catarina. We evaluated 150 individuals of both sexes and over 18 years of age, separated 
between the test and control groups.
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The subjects in the test group underwent an interview, which addressed issues 
related to eating habits, frequency of physical activities and use of drugs. The results 
obtained in the biochemical and anthropometric analyzes were divided between values 
inside and outside the reference value. 
The patients were recruited from basic health units. The protocol of the study was 
approved by the Ethics Committee of the University of West Santa Catarina (Unoesc – 
no 219.091) and all participants provided written informed consent. Obesity status was 
classified according to the criteria established by the World Health Organization.12 The 
participants were non-smokers and were not taking any medications. We selected all 
obese, overweight and non-obese subjects without previous diseases such as diabetes 
mellitus, coronary, stroke, neoplasms, other diseases, or dysfunctions that could influence 
the obese state and genotype distribution.  
2.2 COLLECTION AND STORAGE OF MATERIAL
For the analyzes, 5 mL of blood were collected with syringe, later stored in tubes 
containing anticoagulant (EDTA) and dry tubes without anticoagulant containing gel 
separator.  They were duly identified and taken to the Molecular Biology Laboratory of 
Unoesc – São Miguel do Oeste Campus for further analysis. Anthropometric data of 150 
volunteers were also registered.
2.3 BIOCHEMICAL ANALYSIS
The annalises of glucose, cholesterol, triglycerides, and HDL-cholesterol levels 
were performed at Cobas Mira (Roche Diagnostics, Basel, Switzerland) clinical chemistry 
analyzer using commecially available assay kits reagents by Labtest Diagnostics®, Lagoa 
Santa, Brazil) according to manufacturer, all analyses were performed at Cobas Mira (Roche 
Diagnostics, Basel, Switzerland) clinical chemistry analyzer using standard methods. LDL-
cholesterol levels were calculated using the Friedewald formula.13
Insulin was determined by electrochemiluminescence immunoassay (Biomedix 
diagnóstica, São Paulo, Brazil) using an Elecsys 2010 analyzer (Roche diagnostics®, Basel, 
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Switzerland). Insulin resistance index was calculated by homeostasis model assessment 
of insulin resistance (HOMA-IR) as: (fasting insulin mIU/L) × (fasting glucose mg/dL)/22.5. 
Glycated hemoglobin (HbA1c) was measured by high-performance liquid chromatography 
(HPLC) (Tosoh 2.2 Plus A1C, Tosoh Corporation, Tokyo, Japan) method, certified by 
the National Glycohemoglobin Standadization Program and is standardized by the 
International Federation of Clinical Chemistry. GME was estimated using the following 
formula: 28.7 x A1C - 46.7 as recommended by the American Diabetes Association (ADA)
2.4 MOLECULAR ANALYSIS
The technique used for the genetic analyzes was the Polymerase Chain Reaction 
(PCR), performed through the Phusion Blood Direct PCR Kit (Thermo Scientific®, 
Massachussetts, USA). The reaction of PCR from the kit was run in a final volume of 20 
μL, using buffer containing all reagents for extraction, DNA polymerase, specific primers, 
sterile water and sample DNA.
The amplifications were performed through a Thermocycler apparatus (Biocycler®, 
China), which subjected the samples to cycles with denaturation temperatures, annealing of 
the primers and extension of the DNA strand of the region of interest. The reaction products 
were digested by the restriction enzyme MspI (Thermo Scientific®, Massachussetts, USA), for 
the 5HT2A gene and then separated by agarose gel electrophoresis for further visualization 
with ultraviolet light. Amplification product sizes were compared to specific standards. In the 
T102C polymorphism of the 5HT2A gene, the T allele presented blunt restriction enzyme 
with a band at 342 base pairs (bp) and the C allele had two 216bp and 126bp DNA bands.
2.5 ANTHROPOMETRIC AND PRESSORIC ANALYSIS
The techniques used to obtain the anthropometric measurements were performed 
according to Anthropometric Standardization Reference Manual. Three measures were 
taken, and the average between them was considered valid. The height was measured in 
centimeters (cm), in a wall stadiometer (Professional ES2020 Sanny®, Brazil). The weight 
was verified in kilograms (kg) in a scale (model Glass 180, platform type, G-tech, Brazil). 
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The Body Mass Index (BMI) was expressed in kg/m2, according to the Brazilian Society 
of Obesity. Systolic Arterial Pressures (PAS) and Diastolic Blood Pressures (PAD) were 
measured in the seated position, after 10 minutes of rest. The right arm was supported 
at the cardiac level and used a pressure device with an auscultatory sphygmomanomet 
(BectonDicknson, BD®, Franklin Lakes, USA). All measurements were taken on the left side 
of the body.14,15 During the anthropometric measurements, all participants were barefoot 
and clothed appropriately.
2.6 STATISTICAL ANALYSIS
The allelic and genotype frequencies of the population were calculated, and 
individuals with kinship were excluded to avoid frequency deviation. The data were 
evaluated to know if the frequencies are in Hardy-Weinberg equilibrium. The distribution 
of allele and genotype frequencies were submitted to the Chi-square test, values  of 
p<0.05 were considered significant. Data analysis was performed using SPSS software 
(version 19.0).
3 RESULTS
The absolute values of serum and anthropometric determinations are given in Table 
1. Differences between observed and expected genotype frequencies were observed for 
individuals with normal triglyceride levels (p = 0.0119), normal BMI (0.0037) and normal 
glycated hemoglobin (p = 0.035). The studied population is not found in Hardy-Weinberg 
equilibrium (p<0.05). For individuals with PAD (p = 0.3681), GMe (p = 0.0228) and HOMA-
IR (p = 0.0010) all altered, a higher frequency of C alleles was observed, whereas for 
individuals with normal GMe (p = 0.0270) a greater frequency of the T allele was observed. 
There was no difference regarding the distribution of the alleles between the normal (N) 
and altered (A) groups for the triglyceride (N, p = 1.0000); A, p = 0.9203), HDL cholesterol 
(N, p = 0.3681; A, p = 0.9203), total cholesterol (N, p = 0.9203, A, p = 0.9203), glycated 
hemoglobin p = 0.7642) and Insulin (N, p = 0.4839; A, p = 0.1936) parameters. The 
distribution of the alleles between the groups, normal diastolic (p = 0.3681) and HOMA-IR 
(p = 0.9203) groups did not reach statistical difference (Table 2).
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Table 1 – Biochemical and anthropometric profiles of study participants
Parameters Results  p value
Triglycerides (mg/dL) - Normal 89.75(±29.12) < 0.0001
Triglycerides (mg/dL) -  Altered 239(±92.26)
HDL-cholesterol (mg/dL) - Normal 51.50(±7.55) < 0.0001
HDL-cholesterol (mg/dL) - Altered 31.89(±5.21)
LDL-cholesterol (mg/dL) - Normal 97.03(±20.73) < 0.0001
LDL-cholesterol (mg/dL) - Altered 158.90(±22.60)
Cholesterol (mg/dL) - Altered 147.03(±14.10) < 0.0001
Cholesterol (mg/dL) - Normal 210.50(±30.39)
HbA1c (%) - Altered 5.42(±0.25) < 0.0001
HbA1c (%) - Normal 6.68(±1.64)
Insulin (uUI/mL) - Normal 10.61(±3.93) < 0.0001
Insulin (uUI/mL) - Altered 33.15(±14.51)
HOMA-IR - Normal 2.49(±0.78) < 0.0001
HOMA-IR - Altered 7.80(±6.30)
GMe (mg/dL) - Normal 115.41(±13.02) < 0.0001
GMe (mg/dL) - Altered 163.79(±53.61)
PAD (mmHg) - Normal 6,83±(1,29) < 0.0001
PAD (mmHg) - Altered 7,9±(1,19)
PAS (mmHg) - Normal 11.61 (±1.50) < 0.0001
PAS (mmHg) - Altered 14.85(±1.02)
BMI (kg/m2) - Normal 28.06(±1.47) < 0.0001
BMI (kg/m2) - Altered 39.59(±5.28)
Note: Data are expressed as means ± SD or median (interquartile ranges); Data were processed for analysis 
Mann-Whitney; PAD: Diastolic Blood Pressure; BMI: Body Mass Index; GMe: Estimated Mean Glycemia; HbA1c: 
Glycated hemoglobin; T: T allele (band at 342 base pairs); C: C allele had two (216 base pairs and 126 base 
pairs).
Table 2 – Allelic frequencies of the polymorphism of the 5HT2A T102C gene, according to biochemical and 
anthropometric marker
Parameters T C  p value ᵡ2 value
Triglycerides (mg/dL) - Normal 50 50 1.000 0.00
Triglycerides (mg/dL) -  Altered 45 55 0.9203 0.04
HDL-cholesterol (mg/dL) - Normal 45 55 0.3681 1.00
HDL-cholesterol (mg/dL) - Altered 49 51 0.9203 0.04
LDL-cholesterol (mg/dL) - Normal 45 55 0.3681 1.00
LDL-cholesterol (mg/dL) - Altered 50 50 0.9203 0.18
Cholesterol (mg/dL) - Altered 49 51 0.9203 0.04
Cholesterol (mg/dL) - Normal 50 50 1.000 0.00
HbA1c (%) - Altered 52 48 0.7642 0.16
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Parameters T C  p value ᵡ2 value
HbA1c (%) - Normal 44 56 0.2713 1.44
Insulin (uUI/mL) - Normal 46 54 0.4839 0.64
Insulin (uUI/mL) - Altered 57 43 0.1936 1.96
HOMA-IR - Normal 51 49 0.9203 0.04
HOMA-IR - Altered 33 67 0.0010* 11.56
GMe (mg/dL) - Normal 61 39 0.0270* 5.343
GMe (mg/dL) - Altered 38 63 0.0228* 5.467
PAD (mmHg) - Normal 45 55 0.3681 1.00
PAD (mmHg) - Altered 24 76 <0.0001* 27.04
BMI (kg/m2) - Normal 50 50 1.000 0.00
BMI (kg/m2) - Altered 47 53 0.6171 0.36
Note: The allele frequency distribution was expressed in%. The data were analyzed by the chi-square test, 
being considered significant p ≤ 0.05; PAD: Diastolic Blood Pressure; BMI: Body Mass Index; GMe: Estimated 
Mean Glycemia; HbA1c: Glycated hemoglobin; T: T allele (band at 342 base pairs); C: C allele had two (216 base 
pairs and 126 base pairs).
4 DISCUSSION
The T102C polymorphism is related to the amount of 2A receptors on the cell 
membrane in humans. It is known that the C allele presents a 20% lower serotonin 
expression than the T allele. The results found suggest that a lower level of serotonin 
reflects on GMe, HOMA-IR and PAD. When related to allele frequencies and GMe, HOMA-
IR and PAD values reached significant differences, confirming its association with the C 
allele. Low levels of serotonin or problems in signaling with its receptor have been related 
to an increase in the desire for higher carbohydrate intake16 among several species, under 
various experimental conditions. There is strong evidence that the increase in the post-
synaptic activity of the serotonergic receptors subsequently causes reduction in amount of 
food eaten during a meal and modifies the feeding pattern.17,18 Thus, knowing that HOMA-
IR and GMe are related to glucose homeostasis, the association of the altered dosages 
of these markers to the C allele is possibly a reflection of the higher caloric intake and 
lower satiety due to the lower serotonin reuptake.16 The lack of measurement of habitual 
energy intake (diet record), was not carried out in this study and representes a important 
limitation, but that does not detract from the presented data.
Other pharmacological and genetic studies have also shown direct effects of 
5-HT2C on glucose homeostasis. Bechtholt, Smith, Gaughan and Lucki3 reported the role 
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of the 5-HT2C receptor on glucose homeostasis in rodents. The rats treated with serotonin 
reuptake inhibitors showed an improvement in glucose tolerance and the interaction 
between serotonin and leptin in glucose homeostasis makes the serotonergic system a 
possible target for the treatment of diabetes and obesity.19 Ward, Jackson, Lefever and 
Tallarida20 and Wade, Juneja, MacKay, Graham, Havel, Tecott, et al.21 found that rats without 
the serotonergic (5-HT) receptor became hyperphagic and obese. In humans, 5-HT indirect 
agonist (fenfluramine and dexfenfluramine) has been used for a few years to treat obesity 
by producing significant weight loss and sustained decrease in appetite.
In a study, dexfenfluramine was administered to rats with free access to food. 
Following the administration of the substance, there was a drastic reduction in food 
consumption, especially those containing sugar. In this study, we can highlight that 
the higher concentration of serotonin is associated with a marked decrease in sugar 
consumption, whereas in our study, individuals with the allele (C) associated with lower 
serotonin expression presented an imbalance in glucose homeostasis, suggesting that 
these appear to have higher sugar consumption.22 Other studies related the T102C 
polymorphism of the 5-HT2A gene to the prevalence of cardiovascular diseases, acute 
myocardial infarction and cholesterolemia.23,24
In a study using animal model, Lopez-Esparza, Berumen, Padilla, Miledi and 
García-Alcocer25 demonstrated modifications in the expression of the 5-HT 2A and 5HT 
2C alleles in the hippocampus of mice with diet-induced obesity supplemented with 
tryptophan, suggesting that the hypercaloric diet causes reduction in receptor expression, 
contributing to the development and progression of obesity. Spadaro, Naug, Du Toit, 
Donner, Colson26 found significant differences in the allelic frequencies of the 5HT2A gene 
between a control population and an obese population in Poland, suggesting a correlation 
between polymorphism and obesity. In a neuropsychological and behavioral study, they 
demonstrated that agonism of 5HT2A receptors is related to satiety and reduction of 
food intake. Allelic frequencies of the 5-HT2A genotype presented significant differences 
between the control and obese population, suggesting the relation between the expression 
of the receptor and the prevalence of the disease.27
Drugs that inhibit the reuptake of 5-HT neurotransmitters, allowing them to remain 
in greater amounts and for a longer time in the synaptic cleft, promote a greater sensation 
of satiety and, in experimental studies, demonstrate an increase in basal metabolism.10 
Serotoninergic circuits have been used for some time as an excellent target for the design 
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of drugs to treat obesity. Drugs such as dexfenfluramine act to block the reuptake of 
serotonin in post-synaptic terminals of the serotonergic circuits, promoting the sensation 
of satiety and reducing the craving for carbohydrates and fats in detriment of protein 
intake. However, the role of the genes encoding serotonin receptors in the pathogenesis 
of obesity has not yet been fully elucidated.28,29 
Thus, the data presented here corroborate with other studies that demonstrated 
the relationship of the T102C polymorphism of the 5HT2A gene to the regulation of 
appetite and energy homeostasis.29 Thus, we also highlight the important role of the brain 
and central nervous system on eating behavior and on the influence on hypertension.13,19
5 CONCLUSION
From the genotypic analyzes of the T102C polymorphism of the 5HT2A gene, 
it was possible to demonstrate a relationship between the presence of the C allele with 
biochemical and anthropometric markers related to obesity and hypertension. These 
results corroborate the use of the regulation of serotonergic circuits in the control of food 
intake, serving as a subsidy for strategies to prevent hypertension and obesity.
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